相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Physics of Cellular Decision Making During Epithelial–Mesenchymal Transition
Shubham Tripathi et al.
Annual Review of Biophysics (2020)
C/EBPα is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transition
Ana Rita Lourenco et al.
NATURE COMMUNICATIONS (2020)
Monoubiquitination of p120-catenin is essential for TGFβ-induced epithelial-mesenchymal transition and tumor metastasis
Qingang Wu et al.
SCIENCE ADVANCES (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
Judith E. den Ouden et al.
Oncotarget (2020)
WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer
Anna Kotrbova et al.
THERANOSTICS (2020)
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Mohit Kumar Jolly et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
Nele Loret et al.
CANCERS (2019)
Ascites from Ovarian Cancer Induces Novel Fucosylated Proteins
Dulce Rosario Alberto-Aguilar et al.
CANCER MICROENVIRONMENT (2019)
Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer
Yanting Hu et al.
CANCER LETTERS (2019)
Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma
Qian Song et al.
ONCOTARGETS AND THERAPY (2019)
Long noncoding RNA LINC00673 promotes the proliferation and metastasis of epithelial ovarian cancer by associating with opioid growth factor receptor
Tingting Zheng et al.
ONCOTARGETS AND THERAPY (2019)
CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress
Jun Shi et al.
BMC CANCER (2019)
Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
Koji Yamanoi et al.
SCIENTIFIC REPORTS (2019)
Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer
Jagmohan Hooda et al.
CANCER RESEARCH (2019)
The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells
Martyna Pakula et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Prognostic Role of Epithelial-Mesenchymal Transition Markers E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63 in Bladder Carcinoma
Rabab Ahmed Moussa et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Roles of miR-200 family members in lung cancer: more than tumor suppressors
Cong Liu et al.
FUTURE ONCOLOGY (2018)
Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites
Sungsik Kim et al.
SCIENTIFIC REPORTS (2018)
Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer
Rosa Mistica C. Ignacio et al.
IMMUNE NETWORK (2018)
Stem cell fate in cancer growth, progression and therapy resistance
Nikki K. Lytle et al.
NATURE REVIEWS CANCER (2018)
The Transcription Factor ZEB2 Is Required to Maintain the Tissue-Specific Identities of Macrophages
Charlotte L. Scott et al.
IMMUNITY (2018)
Epithelial-mesenchymal transition in tumor metastasis
Kay T. Yeung et al.
MOLECULAR ONCOLOGY (2017)
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
U. Saini et al.
ONCOGENE (2017)
Title Prognosis Significance of ZEB2 and TGF-1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer
Zhen Yan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition
Pui-Wah Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
Soochi Kim et al.
CANCER SCIENCE (2016)
Placental Growth Factor Promotes Ovarian Cancer Cell Invasion via ZEB2
Ning Song et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78
Lihong Mo et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma
Changmei Liu et al.
TUMOR BIOLOGY (2015)
The ZNF304-integrin axis protects against anoikis in cancer
Burcu Aslan et al.
NATURE COMMUNICATIONS (2015)
Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
Da Yang et al.
CANCER CELL (2013)
Molecular Identification of GD3 as a Suppressor of the Innate Immune Response in Ovarian Cancer
Tonya J. Webb et al.
CANCER RESEARCH (2012)
Transformation of Epithelial Ovarian Cancer Stemlike Cells into Mesenchymal Lineage via EMT Results in Cellular Heterogeneity and Supports Tumor Engraftment
Hua Jiang et al.
MOLECULAR MEDICINE (2012)
Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients
Trevor G. Shepherd et al.
NATURE PROTOCOLS (2006)
DNA methylation in ovarian cancer - II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells
A Ahluwalia et al.
GYNECOLOGIC ONCOLOGY (2001)
分享论文
